# Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

> **NCT02958956** · — · COMPLETED · sponsor: **Takeda** · enrollment: 236507 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2, Cancer

## Interventions

- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT02958956
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1997-01-01
- **Primary completion:** 2015-05-29
- **Final completion:** 2015-05-29
- **Target enrollment:** 236507 (ACTUAL)
- **Last updated:** 2018-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02958956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02958956, "Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT02958956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*